BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23973167)

  • 21. Differential contributions of monocyte- and platelet-derived microparticles towards thrombin generation and fibrin formation and stability.
    Aleman MM; Gardiner C; Harrison P; Wolberg AS
    J Thromb Haemost; 2011 Nov; 9(11):2251-61. PubMed ID: 21883880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microparticle-associated tissue factor activity is reduced by inhibition of the complement protein 5 in Neisseria meningitidis-exposed whole blood.
    Øvstebø R; Hellum M; Aass HC; Trøseid AM; Brandtzaeg P; Mollnes TE; Henriksson CE
    Innate Immun; 2014 Jul; 20(5):552-60. PubMed ID: 24051102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infections.
    Woei-A-Jin FJ; van der Starre WE; Tesselaar ME; Garcia Rodriguez P; van Nieuwkoop C; Bertina RM; van Dissel JT; Osanto S
    Thromb Res; 2014 May; 133(5):799-803. PubMed ID: 24657035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microparticle-associated tissue factor activity: a link between cancer and thrombosis?
    Tesselaar ME; Romijn FP; Van Der Linden IK; Prins FA; Bertina RM; Osanto S
    J Thromb Haemost; 2007 Mar; 5(3):520-7. PubMed ID: 17166244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients.
    Thaler J; Ay C; Mackman N; Bertina RM; Kaider A; Marosi C; Key NS; Barcel DA; Scheithauer W; Kornek G; Zielinski C; Pabinger I
    J Thromb Haemost; 2012 Jul; 10(7):1363-70. PubMed ID: 22520016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement of microparticle tissue factor activity in clinical samples: A summary of two tissue factor-dependent FXa generation assays.
    Hisada Y; Alexander W; Kasthuri R; Voorhees P; Mobarrez F; Taylor A; McNamara C; Wallen H; Witkowski M; Key NS; Rauch U; Mackman N
    Thromb Res; 2016 Mar; 139():90-7. PubMed ID: 26916302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue factor expression, angiogenesis, and thrombosis in pancreatic cancer.
    Khorana AA; Ahrendt SA; Ryan CK; Francis CW; Hruban RH; Hu YC; Hostetter G; Harvey J; Taubman MB
    Clin Cancer Res; 2007 May; 13(10):2870-5. PubMed ID: 17504985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo.
    Mezouar S; Darbousset R; Dignat-George F; Panicot-Dubois L; Dubois C
    Int J Cancer; 2015 Jan; 136(2):462-75. PubMed ID: 24889539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers.
    Langer F; Chun FK; Amirkhosravi A; Friedrich M; Leuenroth S; Eifrig B; Bokemeyer C; Francis JL
    Thromb Haemost; 2007 Mar; 97(3):464-70. PubMed ID: 17334515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer.
    Hron G; Kollars M; Weber H; Sagaster V; Quehenberger P; Eichinger S; Kyrle PA; Weltermann A
    Thromb Haemost; 2007 Jan; 97(1):119-23. PubMed ID: 17200778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Platelet microparticles and vascular cells interactions: a checkpoint between the haemostatic and thrombotic responses.
    Morel O; Morel N; Freyssinet JM; Toti F
    Platelets; 2008 Feb; 19(1):9-23. PubMed ID: 18231934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulant effects of an antidiabetic drug on monocytes in vitro.
    Henriksson CE; Hellum M; Haug KB; Aass HC; Joø GB; Øvstebø R; Trøseid AM; Klingenberg O; Kierulf P
    Thromb Res; 2011 Nov; 128(5):e100-6. PubMed ID: 21862110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic cancer cell and microparticle procoagulant surface characterization: involvement of membrane-expressed tissue factor, phosphatidylserine and phosphatidylethanolamine.
    Yates KR; Welsh J; Echrish HH; Greenman J; Maraveyas A; Madden LA
    Blood Coagul Fibrinolysis; 2011 Dec; 22(8):680-7. PubMed ID: 21941170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue factor exposing microparticles in inflammatory bowel disease.
    Palkovits J; Novacek G; Kollars M; Hron G; Osterode W; Quehenberger P; Kyrle PA; Vogelsang H; Reinisch W; Papay P; Weltermann A
    J Crohns Colitis; 2013 Apr; 7(3):222-9. PubMed ID: 22705067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluorescent particles in the antibody solution result in false TF- and CD14-positive microparticles in flow cytometric analysis.
    Aass HC; Øvstebø R; Trøseid AM; Kierulf P; Berg JP; Henriksson CE
    Cytometry A; 2011 Dec; 79(12):990-9. PubMed ID: 21990118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monocytes and tissue factor promote thrombosis in a murine model of oxygen deprivation.
    Lawson CA; Yan SD; Yan SF; Liao H; Zhou YS; Sobel J; Kisiel W; Stern DM; Pinsky DJ
    J Clin Invest; 1997 Apr; 99(7):1729-38. PubMed ID: 9120018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venous thromboembolism in patients with pancreatic cancer: implications of circulating tissue factor.
    Delluc A; Rousseau A; Delluc C; Le Moigne E; Le Gal G; Mottier D; Van Dreden P; Lacut K
    Blood Coagul Fibrinolysis; 2011 Jun; 22(4):295-300. PubMed ID: 21372691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration.
    Gori AM; Pepe G; Attanasio M; Falciani M; Abbate R; Prisco D; Fedi S; Giusti B; Brunelli T; Giusti B; Brunelli T; Comeglio P; Gensini GF; Neri Serneri GG
    Thromb Haemost; 1999 Apr; 81(4):589-93. PubMed ID: 10235445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered fibrin clot properties in advanced lung cancer: strong impact of cigarette smoking.
    Ząbczyk M; Królczyk G; Czyżewicz G; Plens K; Prior S; Butenas S; Undas A
    Med Oncol; 2019 Mar; 36(4):37. PubMed ID: 30891644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered plasma fibrin clot properties in patients with digestive tract cancers: links with the increased thrombin generation.
    Gronostaj K; Richter P; Nowak W; Undas A
    Thromb Res; 2013 Mar; 131(3):262-7. PubMed ID: 23273404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.